We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Protein Bridge Stabilizes Growth Regulatory Pathway

By Biotechdaily staff writers
Posted on 15 May 2003
Researchers studying the molecular clues that stimulate cell growth have identified a protein called GâL, which stabilizes the interactions of other proteins comprising the mTOR regulatory pathway.

A protein called mTOR (mammalian target of rapamycin) and a protein called raptor (regulatory associated protein of mTOR) are components of a signaling pathway that regulates mammalian cell growth in response to nutrients and growth factors. More...
Knowledge of the link between mTOR and cell growth had emerged from work done on the effects of the powerful immunosuppresant rapamycin. Those studies showed that rapamycin blocked the activity of mTOR, while additional research revealed that raptor cooperated with the mTOR protein to directly regulate cell size in response to nutrient levels.

In the current study, reported in the April 2003 issue of Molecular Cell, investigators at the Whitehead Institute for Biomedical Research (Cambridge, MA, USA) described a third protein, GâL, which acts as a bridge to stabilize the interaction between the mTOR protein and raptor. The proper balance and activity of theses proteins determine whether the cell will grow in response to nutrient clues.

"As we learn more about mTOR at the cellular level, we can begin to understand its function in the regulation of growth throughout the body,” explained senior author Dr. David Sabatini, a researcher at the Whitehead Institute. "This complex has opened up a window onto how nutrient signaling is involved in different mammalian processes and provide a new way to investigate the role nutrients and metabolism play in disease. In some cases, a cell becomes insensitive to nutrient signaling and growth goes out of control. This suggests that the role of nutrients and signaling has been underestimated in the study of cancer.”


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.